Advertisement

Archives of Gynecology and Obstetrics

, Volume 298, Issue 5, pp 933–938 | Cite as

Hemodynamic effects of intramyometrial epinephrine injection for blood loss reduction in laparoscopic myomectomy

  • Jana Nickol
  • Sebastian Berlit
  • Stefanie Lis
  • Amadeus Hornemann
  • Charalambos Tsagogiorgas
  • Marc Sütterlin
  • Benjamin Tuschy
General Gynecology
  • 16 Downloads

Abstract

Purpose

To evaluate changes in hemodynamic effects of intramyometrial epinephrine injection for blood loss reduction in laparoscopic myomectomy.

Methods

A total of 185 women with symptomatic uterine fibroids who underwent laparoscopic myomectomy were enrolled in this study. Eighty-six women (study collective) received an intramyometrial injection of epinephrine and were compared to ninety-nine women (control collective) who underwent laparoscopic myomectomy without an intramyometrial epinephrine injection. Demographic parameters, change of hemodynamic parameters during surgery as well as hemoglobin drop after surgery were analyzed.

Results

In the study collective maximum systolic blood pressure (p < 0.001), maximum increase of the systolic blood pressure within 5 min (p = 0.003), duration of hypertension (p = 0.012), maximal (p < 0.001) and mean heart rate (p = 0.005), maximal increase of heart rate within 5 min (p = 0.003) and difference of mean to maximal heart rate (p < 0.001) were higher compared to the control collective. There was no difference in pre- and postoperative hemoglobin levels in both collectives and no intraoperative clinically relevant complication occurred due to intramyometrial epinephrine injection.

Conclusion

The intramyometrial application of epinephrine seems to be safe but leads to significant alterations of hemodynamic parameters without a significant change in postoperative hemoglobin levels.

Keywords

Laparoscopic myomectomy Intramyometrial epinephrine Fibroid Hemodynamic effect 

Notes

Author contributions

JN: protocol development, manuscript writing. SB: manuscript editing. SL: data analysis. AH: data collection. CT: protocol development. MS: protocol development. BT: manuscript writing, protocol development.

Funding

There was no funding involved in the conduction of this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical approval was given by the Ethics Committee II at Heidelberg University, Heidelberg, Germany on 8 May 2018, reference number 2018-838R-MA.

References

  1. 1.
    Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100–107CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Okolo S (2008) Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22(4):571–588.  https://doi.org/10.1016/j.bpobgyn.2008.04.002 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, Subramanian D (2010) The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 152(1):96–102.  https://doi.org/10.1016/j.ejogrb.2010.05.012 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Donnez J, Dolmans MM (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update 22(6):665–686.  https://doi.org/10.1093/humupd/dmw023 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Beckmann MW, Juhasz-Boss I, Denschlag D, Gass P, Dimpfl T, Harter P, Mallmann P, Renner SP, Rimbach S, Runnebaum I, Untch M, Brucker SY, Wallwiener D (2015) Surgical methods for the treatment of uterine fibroids—risk of uterine sarcoma and problems of morcellation: position paper of the DGGG. Geburtshilfe Frauenheilkd 75(2):148–164.  https://doi.org/10.1055/s-0035-1545684 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, Guido M, Alkatout I, Schollmeyer T (2014) Impact of surgical approach on blood loss during intracapsular myomectomy. Minim Invasive Ther Allied Technol 23(2):87–95.  https://doi.org/10.3109/13645706.2013.839951 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Kalogiannidis I, Xiromeritis P, Prapas N, Prapas Y (2011) Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol 38(1):46–49PubMedPubMedCentralGoogle Scholar
  8. 8.
    Assef A (1999) Adhesions after laparoscopic myomectomy: effect of the technique used. Gynaecol Endosc 8(4):225–229CrossRefGoogle Scholar
  9. 9.
    Wang CJ, Lee CL, Yuen LT, Kay N, Han CM, Soong YK (2007) Oxytocin infusion in laparoscopic myomectomy may decrease operative blood loss. J Minim Invasive Gynecol 14(2):184–188.  https://doi.org/10.1016/j.jmig.2006.09.016 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Zullo F, Palomba S, Corea D, Pellicano M, Russo T, Falbo A, Barletta E, Saraco P, Doldo P, Zupi E (2004) Bupivacaine plus epinephrine for laparoscopic myomectomy: a randomized placebo-controlled trial. Obstet Gynecol 104(2):243–249.  https://doi.org/10.1097/01.AOG.0000132801.41880.e8 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Kongnyuy EJ, Wiysonge CS (2014) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 8:CD005355.  https://doi.org/10.1002/14651858.cd005355.pub5 CrossRefGoogle Scholar
  12. 12.
    Wong AS, Cheung CW, Yeung SW, Fan HL, Leung TY, Sahota DS (2014) Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: a randomized controlled trial. Obstet Gynecol 124(5):897–903.  https://doi.org/10.1097/AOG.0000000000000515 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kathiresan AS, Brookfield KF, Gonzalez-Quintero VH, Verma U (2011) Vasopressin versus a combination of vasopressin and tourniquets: a comparison of blood loss in patients undergoing abdominal myomectomies. Aust N Z J Obstet Gynaecol 51(1):79–83.  https://doi.org/10.1111/j.1479-828X.2010.01253.x CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Cohen SL, Wang KC, Gargiulo AR, Srouji S, Goggins ER, Solnik J, Tu F, Senapati S, Hur HC, Einarsson JI (2015) Vasopressin administration during laparoscopic myomectomy: a randomized controlled trial. J Minim Invasive Gynecol 22(6S):S39.  https://doi.org/10.1016/j.jmig.2015.08.110 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Canseco-Lima JM, Hernandez-Denis A, Audifred-Salomon J (2015) Vasopressin myoma infiltration during hysteroscopic myomectomy. J Minim Invasive Gynecol 22(6S):S123.  https://doi.org/10.1016/j.jmig.2015.08.364 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W (2013) A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril 100(4):1044–1049.  https://doi.org/10.1016/j.fertnstert.2013.06.022 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ (2015) Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 195:177–181.  https://doi.org/10.1016/j.ejogrb.2015.10.003 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Wenzel V, Lindner KH (2001) Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc Res 51(3):529–541CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Nezhat F, Admon D, Nezhat CH, Dicorpo JE, Nezhat C (1994) Life-threatening hypotension after vasopressin injection during operative laparoscopy, followed by uneventful repeat laparoscopy. J Am Assoc Gynecol Laparosc 2(1):83–86CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Riess ML, Ulrichs JG, Pagel PS, Woehlck HJ (2011) Case report: severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg 113(5):1103–1105.  https://doi.org/10.1213/ANE.0b013e31822cef10 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Tulandi T, Beique F, Kimia M (1996) Pulmonary edema: a complication of local injection of vasopressin at laparoscopy. Fertil Steril 66(3):478–480CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Jayaraman L, Sinha A, Punhani D (2013) Intramyometrial vasopressin: anesthesiologists’ nightmare. J Anaesthesiol Clin Pharmacol 29(1):135–136.  https://doi.org/10.4103/0970-9185.105832 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lurie S, Mamet Y (2000) Transient myocardial ischemia may occur following subendometrial vasopressin infiltration. Eur J Obstet Gynecol Reprod Biol 91(1):87–89CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Nassif J, Nahouli H, Khalil A, Mikhael E, Gharzeddine W, Ghaziri G (2017) Epinephrine-induced takotsubo cardiomyopathy during laparoscopic myomectomy: case report and review of the literature. J Minim Invasive Gynecol 24(6):1037–1039.  https://doi.org/10.1016/j.jmig.2017.04.024 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Chudnoff S, Glazer S, Levie M (2012) Review of vasopressin use in gynecologic surgery. J Minim Invasive Gynecol 19(4):422–433CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, University Medical Centre MannheimHeidelberg UniversityMannheimGermany
  2. 2.Institute of Psychiatric and Psychosomatic Psychotherapy, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg UniversityMannheimGermany
  3. 3.Department of Anesthesiology and Critical Care Medicine, University Medical Centre MannheimHeidelberg UniversityMannheimGermany

Personalised recommendations